title: Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease.
abstract: The pathogenic mechanism(s) contributing to loss of dopamine neurons in Parkinson's disease (PD) remain obscure. Leucine-rich repeat kinase 2 (LRRK2) mutations are linked, as a causative gene, to PD. LRRK2 mutations are estimated to account for 10% of familial and between 1 % and 3 % of sporadic PD. LRRK2 proximate single nucleotide polymorphisms have also been significantly associated with idiopathic/sporadic PD by genome-wide association studies. LRRK2 is a multidomain-containing protein and belongs to the protein kinase super-family. We constructed two inducible dopaminergic cell lines expressing either human-LRRK2-wild-type or human-LRRK2-mutant (G2019S). Phenotypes of these LRRK2 cell lines were examined with respect to cell viability, morphology, and protein function with or without induction of LRRK2 gene expression. The overexpression of G2019S gene promoted (1) low cellular metabolic activity without affecting cell viability, (2) blunted neurite extension, and (3) increased phosphorylation at S910 and S935. Our observations are consistent with reported general phenotypes in LRRK2 cell lines by other investigators. We used these cell lines to interrogate the biological function of LRRK2, to evaluate their potential as a drug-screening tool, and to investigate screening for small hairpin RNA-mediated LRRK2 G2019S gene knockdown as a potential therapeutic strategy. A proposed LRRK2 kinase inhibitor (i.e., IN-1) decreased LRRK2 S910 and S935 phosphorylation in our MN9DLRRK2 cell lines in a dose-dependent manner. Lentivirus-mediated transfer of LRRK2 G2019S allele-specific small hairpin RNA reversed the blunting of neurite extension caused by LRRK2 G2019S overexpression. Taken together, these inducible LRRK2 cell lines are suitable reagents for LRRK2 functional studies, and the screening of potential LRRK2 therapeutics.
authors: Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA.
authors: Liang
authors: L
authors: Huang
authors: Mika
authors: M
authors: Shimoji
authors: Juan
authors: J
authors: Wang
authors: Salim
authors: S
authors: Shah
authors: Sukanta
authors: S
authors: Kamila
authors: Edward R
authors: ER
authors: Biehl
authors: Seung
authors: S
authors: Lim
authors: Allison
authors: A
authors: Chang
authors: Kathleen A
authors: KA
authors: Maguire-Zeiss
authors: Xiaomin
authors: X
authors: Su
authors: Howard J
authors: HJ
authors: Federoff
mesh_terms: D002460:Cell Line; D002470:Cell Survival / Q000235:genetics; D059290:Dopaminergic Neurons / Q000378:metabolism; D006801:Humans; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D010300:Parkinson Disease / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics* / Q000378:metabolism
chemical_list: C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases
references: PLoS One. 2011 Apr 06;6(4):e18568
references: 21494637
references: Lancet. 2005 Jan 29-Feb 4;365(9457):415-6
references: 15680457
references: Hum Mol Genet. 2007 Sep 1;16(17):2031-9
references: 17584768
references: FEBS Lett. 2011 Jul 21;585(14):2165-70
references: 21658387
references: Biochem J. 2010 Sep 15;430(3):405-13
references: 20659021
references: Curr Neurol Neurosci Rep. 2012 Jun;12(3):251-60
references: 22441981
references: Neurology. 2005 Sep 13;65(5):696-700
references: 16157901
references: Hum Mutat. 2007 Jul;28(7):641-53
references: 17385668
references: Neuron. 2010 Oct 21;68(2):201-6
references: 20955928
references: Lancet. 2005 Jan 29-Feb 4;365(9457):410-2
references: 15680455
references: J Biol Chem. 2010 Sep 17;285(38):29569-76
references: 20595391
references: N Engl J Med. 2006 Jan 26;354(4):422-3
references: 16436781
references: Parkinsonism Relat Disord. 2010 Dec;16(10):650-5
references: 20850369
references: Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2693-8
references: 18258746
references: Nat Neurosci. 2009 Jul;12(7):826-8
references: 19503083
references: J Neurosci Res. 2008 Jun;86(8):1711-20
references: 18214993
references: Nat Neurosci. 2006 Oct;9(10):1231-3
references: 16980962
references: Neuron. 2004 Nov 18;44(4):595-600
references: 15541308
references: Neuron. 2006 Nov 22;52(4):587-93
references: 17114044
references: J Neurosci. 2009 Jul 22;29(29):9210-8
references: 19625511
references: Biochim Biophys Acta. 2009 Jul;1792(7):625-33
references: 18973807
references: Nat Med. 2010 Sep;16(9):998-1000
references: 20729864
references: Neurology. 2005 Sep 13;65(5):738-40
references: 16157908
references: BMC Med Genet. 2011 Aug 03;12:104
references: 21812969
references: Nat Chem Biol. 2011 Apr;7(4):203-5
references: 21378983
references: J Neurochem. 2008 May;105(3):1048-56
references: 18182054
references: Neuron. 2004 Nov 18;44(4):601-7
references: 15541309
references: Biochem Biophys Res Commun. 2009 Jan 16;378(3):473-7
references: 19027715
references: Neurobiol Dis. 2011 Mar;41(3):706-16
references: 21168496
references: Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18676-81
references: 16352719
references: Hum Mol Genet. 2006 Jan 15;15(2):223-32
references: 16321986
references: Nat Rev Neurosci. 2010 Dec;11(12):791-7
references: 21088684
references: FEBS J. 2009 Jan;276(2):466-78
references: 19076219
references: Neurobiol Aging. 2008 Nov;29(11):1690-701
references: 17537546
references: Biochem J. 2010 Sep 15;430(3):393-404
references: 20642453
references: J Neurochem. 2010 Mar;112(6):1593-604
references: 20067578
references: Lancet. 2005 Jan 29-Feb 4;365(9457):412-5
references: 15680456
references: Ann Neurol. 2002 Mar;51(3):296-301
references: 11891824
references: Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14622-7
references: 19667187
references: EMBO J. 2008 Sep 17;27(18):2432-43
references: 18701920
references: Neurosci Lett. 2005 Dec 9;389(3):137-9
references: 16102903
references: Neurology. 2005 Sep 13;65(5):741-4
references: 16157909
references: Neuron. 2010 Jun 10;66(5):646-61
references: 20547124
references: Biochemistry. 2007 Feb 6;46(5):1380-8
references: 17260967
references: PLoS One. 2010 Jan 15;5(1):e8730
references: 20090955
references: Neuron. 2009 Dec 24;64(6):807-27
references: 20064389
references: Hum Mol Genet. 2007 Jan 15;16(2):223-32
references: 17200152
references: Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16842-7
references: 16269541
references: J Neurochem. 2007 Oct;103(1):238-47
references: 17623048
references: Exp Cell Res. 2007 Oct 1;313(16):3658-70
references: 17706965
references: Biochemistry. 2009 Nov 24;48(46):10963-75
references: 19824698
references: Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):8943-7
references: 1357658
references: J Neurochem. 2009 May;109(4):959-68
references: 19302196
references: Neurobiol Dis. 2006 Aug;23(2):329-41
references: 16750377
references: J Neurosci. 2009 Nov 4;29(44):13971-80
references: 19890007
references: Gene. 1999 Mar 18;229(1-2):21-9
references: 10095100
references: PLoS One. 2011 Mar 01;6(3):e17153
references: 21390248
references: N Engl J Med. 2006 Jan 26;354(4):424-5
references: 16436782
references: Sci Transl Med. 2012 Dec 12;4(164):164ra161
references: 23241745
references: Exp Neurol. 2007 Jan;203(1):221-32
references: 16999955
references: PLoS One. 2011;6(10):e26194
references: 22031823
references: Neurosci Lett. 2006 Jul 10;402(1-2):92-6
references: 16632201
references: Exp Neurobiol. 2010 Sep;19(2):97-105
references: 22110348
references: Trends Neurosci. 2006 May;29(5):286-93
references: 16616379
references: Brain Res. 1991 Jun 21;552(1):67-76
references: 1913182
references: Biochem J. 2007 Jul 15;405(2):307-17
references: 17447891